Informacje dodatkowe
| Active substance | Metformin, Voglibose |
|---|---|
| Chemical name | (1S,2R,3R,4R,5S)-5-(2-hydroxy-1-(hydroxymethyl)ethyl)-1,2,3,4-cyclohexanetetrol |
| Side effects | Flatulence, diarrhea, abdominal pain |
| Effects | Reduces postprandial blood glucose levels |
| Dosage (sports) | Not applicable as voglibose is not used for performance enhancement in sports |
| Dosage (medical) | Typically 0.2 mg to 0.3 mg three times a day with the first bite of each main meal |
| Half-life | 1.5 – 4.5 hours |
| Main action | Delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals |
| Substance class | Alpha-glucosidase inhibitor |
| Formula | C10H21NO7 |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Vogliban, Basen, Vocarb |
| Blood pressure | No direct effect |
| Also known as | AO-128 |
| Strength | 0.2/500mg |
| Lab Test | Not specific, generally monitored through blood glucose levels |
| Hepatotoxicity | Low risk |
| Water Retention | No significant effect |
| Use in sports | None |
| Manufacturer | Healing Pharma |
| Packing | 10 tabs/blister |
|
Opinie
Na razie nie ma opinii o produkcie.